Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteome

Proteomics

Volumn 11, Issue 11, 2011, Pages 2275-2282

  Hatakeyama, Keiichi ^a   Ohshima, Keiichi ^a   Fukuda, Yorikane ^b   Ogura, Shun ichiro ^c   Terashima, Masanori ^a   Yamaguchi, Ken ^a   Mochizuki, Tohru ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Biomarkers; Protein isoform; Splicing variant; Technology; Transcriptomics

Indexed keywords

PROTEOME; TRANSCRIPTOME;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; NEOPLASM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ALTERNATIVE SPLICING; CELL LINE, TUMOR; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE EXPRESSION PROFILING; HUMANS; LAMIN TYPE A; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PROTEIN DISULFIDE-ISOMERASES; PROTEIN ISOFORMS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 79956275842     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100016     Document Type: Article

References (45)

1. Mironov, A. A., Fickett, J. W., Gelfand, M. S., Frequent alternative splicing of human genes. Genome Res. 1999, 9, 1288-1293.
2. Brett, D., Hanke, J., Lehmann, G., Haase, S. et al., EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett. 2000, 474, 83-86.
3. Kan, Z., States, D., Gish, W., Selecting for functional alternative splices in ESTs. Genome Res. 2002, 12, 1837-1845.
4. Modrek, B., Resch, A., Grasso, C., Lee, C., Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucl. Acids Res. 2001, 29, 2850-2859.
5. Johnson, J. M., Castle, J., Garrett-Engele, P., Kan, Z. et al., Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003, 302, 2141-2144.
6. Clark, T. A., Schweitzer, A. C., Chen, T. X., Staples, M. K. et al., Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol. 2007, 8, R64.
7. Kampa, D., Cheng, J., Kapranov, P., Yamanaka, M. et al., Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res. 2004, 14, 331-342.
8. Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y. et al., Function of alternative splicing. Gene 2005, 344, 1-20.
9. Becker, K. F., Atkinson, M. J., Reich, U., Becker, I. et al., E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994, 54, 3845-3852.
10. Gayther, S. A., Barski, P., Batley, S. J., Li, L. et al., Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Oncogene 1997, 15, 2119-2126.
11. Ge, K., DuHadaway, J., Du, W., Herlyn, M. et al., Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc. Natl. Acad. Sci. USA 1999, 96, 9689-9694.
12. Barbour, A. P., Reeder, J. A., Walsh, M. D., Fawcett, J. et al., Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3. Cancer Res. 2003, 63, 887-892.
13. Faustino, N. A., Cooper, T. A., Pre-mRNA splicing and human disease. Genes Dev. 2003, 17, 419-437.
14. Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R. et al., The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol. 2007, 14, 185-193.
15. Thorsen, K., Sorensen, K. D., Brems-Eskildsen, A. S., Modin, C. et al., Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol. Cell. Proteomics 2008, 7, 1214-1224.
16. Schutte, M., Elstrodt, F., Bralten, L. B., Nagel, J. H. et al., Exon expression arrays as a tool to identify new cancer genes. PLoS One 2008, 3, e3007.
17. Xi, L., Feber, A., Gupta, V., Wu, M. et al., Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucl. Acids Res. 2008, 36, 6535-6547.
18. French, P. J., Peeters, J., Horsman, S., Duijm, E. et al., Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. Cancer Res. 2007, 67, 5635-5642.
19. Birzele, F., Csaba, G., Zimmer, R., Alternative splicing and protein structure evolution. Nucleic Acids Res. 2008, 36, 550-558.
20. Iinuma, H., Maruyama, K., Okinaga, K., Sasaki, K. et al., Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer. Int. J. Cancer 2002, 99, 130-137.
21. Nishimori, H., Yasoshima, T., Denno, R., Shishido, T. et al., A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: different mechanisms in peritoneal dissemination and hematogenous metastasis. Jpn. J. Cancer Res. 2000, 91, 715-722.
22. Fukui, R., Nishimori, H., Hata, F., Yasoshima, T. et al., Metastases-related genes in the classification of liver and peritoneal metastasis in human gastric cancer. J. Surg. Res. 2005, 129, 94-100.
23. Ogura, S. I., Kaneko, K., Miyajima, S., Ohshima, K. et al., Proneurotensin/neuromedin N secreted from small cell lung carcinoma cell lines as a potential tumor marker. Proteomics Clin. Appl. 2008, 2, 1620-1627.
24. Ichibangase, T., Moriya, K., Koike, K., Imai, K., A proteomics method revealing disease-related proteins in livers of hepatitis-infected mouse model. J Proteome Res. 2007, 6, 2841-2849.
25. Ito, S., Yoshioka, S., Ogata, I., Takeda, A. et al., Nanoflow gradient generator for capillary high-performance liquid chromatography-nanoelectrospray mass spectrometry. J. Chromatogr. A 2004, 1051, 19-23.
26. Robinson, M. D., Speed, T. P., A comparison of Affymetrix gene expression arrays. BMC Bioinformatics 2007, 8, 449.
27. Park, J. G., Frucht, H., LaRocca, R. V., Bliss, D. P. Jr., et al., Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 1990, 50, 2773-2780.
28. Bae, C. D., Park, S. E., Seong, Y. S., Kimm, S. W., Park, J. B., The mechanism of c-erbB-2 gene product increase in stomach cancer cell lines. J. Korean Med. Sci. 1993, 8, 153-159.
29. Bae, C. D., Juhnn, Y. S., Park, J. B., Post-transcriptional control of c-erb B-2 overexpression in stomach cancer cells. Exp. Mol. Med. 2001, 33, 15-19.
30. Black, D. L., Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 2003, 72, 291-336.
31. Blencowe, B. J., Alternative splicing: new insights from global analyses. Cell 2006, 126, 37-47.
32. Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L. et al., Patterns of somatic mutation in human cancer genomes. Nature 2007, 446, 153-158.
33. Gardina, P. J., Clark, T. A., Shimada, B., Staples, M. K. et al., Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 2006, 7, 325.
34. Moller-Levet, C. S., Betts, G. N., Harris, A. L., Homer, J. J. et al., Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis. PLoS Comput. Biol. 2009, 5, e1000571.
35. Penhoet, E. E., Rutter, W. J., Catalytic and immunochemical properties of homomeric and heteromeric combinations of aldolase subunits. J. Biol. Chem. 1971, 246, 318-323.
36. Haimoto, H., Kato, K., Highly sensitive enzyme immunoassay for human brain aldolase C. Clin. Chim. Acta 1986, 154, 203-211.
37. Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B., Simon, M. C., Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell Biol. 2003, 23, 9361-9374.
38. Jean, J. C., Rich, C. B., Joyce-Brady, M., Hypoxia results in an HIF-1-dependent induction of brain-specific aldolase C in lung epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 291, L950-L956.
39. Kim, J. H., Lee, S., Lee, T. G., Hirata, M. et al., Phospholipase D2 directly interacts with aldolase via its PH domain. Biochemistry 2002, 41, 3414-3421.
40. Baron, C. B., Greeley, P., Coburn, R. F., Smooth muscle aldolase C-bound inositol 1, 4, 5-trisphosphate studied in vitro under physiological conditions. Biochim. Biophys. Acta 1998, 1401, 81-92.
41. Sato, S., Sugimura, T., Chien, T. C., Takakura, K., Aldolase isozyme patterns of human brain tumors. Cancer 1971, 27, 223-227.
42. Schapira, F., Hatzfeld, A., Reuber, M. D., Fetal pattern of aldolase in transplantable hepatomas. Cancer Res. 1971, 31, 1224-1230.
43. Ojika, T., Imaizumi, M., Abe, T., Kato, K., Immunochemical and immunohistochemical studies on three aldolase isozymes in human lung cancer. Cancer 1991, 67, 2153-2158.
44. Menon, R., Omenn, G. S., Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers. Cancer Res. 2010, 70, 3440-3449.
45. Ohshima, K., Inoue, K., Fujiwara, A., Hatakeyama, K. et al., Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One 2010, 5, e13247.